R
RNTX
Rein Therapeutics, Inc.
1.210
0.0000.00%After Hours: 1.210 0.000 0.00%16:04 04/02 EDT
OPEN/PREV CLOSE1.170/1.210
TODAY RANGE1.110-1.330
VOL155.08K
MARKET CAP33.93M
52 WEEK RANGE1.020-2.400
AVG VOL (3M)104.26K
% TURNOVER0.55%
TURNOVER--
P/E (TTM)-0.6173
% RANGE18.14%
EPS(TTM)-1.9600
P/E(FORWARD)-0.7423
P/B1.970
BVPS0.6141
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP33.90M
SHARES OUTSTANDING28.04M
NEXT EARNINGS05/13-05/18
FREE FLOAT28.02M
LOT SIZE1
EX-DATE11/11/2022
News
Press Releases
Financial Reports
Profile
Benzinga·03/26 21:55
Rein Therapeutics Q4 Adj. EPS $(0.11) Beats $(0.24) Estimate
Reuters·03/03 13:02
Rein Therapeutics Doses First Patient in Phase 2 IPF Trial of LTI-03
TipRanks·03/02 11:43
Rein Therapeutics Completes Private Placement of Notes
Reuters·03/02 11:10
Rein Therapeutics enters $2.875 million promissory note financing deal
TipRanks·02/19 22:28
Rein Therapeutics Announces Immediate Board Director Resignation
Reuters·02/19 21:38
Rein Therapeutics Director Manuel C. Alves Aivado Resigns
Dow Jones·01/21 16:13
Rein Therapeutics Cut to Hold From Buy by Brookline Capital
Benzinga·01/21 16:03
Brookline Capital Downgrades Rein Therapeutics to Hold
TipRanks·01/21 14:20
Rein Therapeutics downgraded to Hold from Buy at Brookline
Reuters·01/20 18:44
BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Seagate, Western Digital
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.